secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0000950170-23-024074
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences prices $16.5M registered direct offering of 3M shares at $5.50/share
--------------------------------------------------------------------------------

- Sold 3,000,000 shares at $5.50 each for gross proceeds of ~$16.5M; net proceeds ~$15.2M.
- Offering includes participation from current investors Dialectic Life Sciences, Hunt Family affiliates, and management.
- Proceeds to fund cytisinicline development for smoking cessation and for working capital.
- Expected to close on or about May 30, 2023; Lake Street Capital Markets as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000095017023024074/0000950170-23-024074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000095017023024074/achv-20230525.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-024074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer